BeStock  
Markets › Compare › ACRS vs CTMX

ACRS vs CTMX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ACRS · Aclaris Therapeutics$3.40 ▼ 8.11%
CTMX · CytomX$2.55 ▼ 0.39%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

58131205278351Oct 9, '25Apr 9, '26Oct 7, '26
  • ACRS +74.4%
  • CTMX -26.1%

Head to head

MetricACRSCTMX
Price$3.40$2.55
Change today▼ 8.11%▼ 0.39%
Market cap$500.48M$555.64M
Return, 3 months-40.5%-35.5%
Return, year to date+13.0%-40.1%
Return, 1 year+78.9%-24.3%
P/E (TTM)-5.9-4.5
P/B4.01.8
P/E percentile vs own 5y–25th
Dividend yield––
Revenue growth (YoY, latest qtr)–-92.4%
Net profit growth (YoY)–-13,319.5%
Gross margin––
Operating margin–-476.2%
Net margin–-435.2%
Return on equity–-37.8%
Analyst target vs. price+252.9%+419.6%
Analyst buy share100%100%
RSI (14)2232
30-day volatility84.0%72.2%
Max drawdown, 1 year-48.0%-62.2%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CTMX is the largest of the group by market value.
  • ACRS has returned the most over the past year.
  • ACRS carries the lowest trailing P/E.
  • CTMX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top